Increased Excess Pressure After Creation of an Arteriovenous Fistula in End-Stage Renal Disease

被引:2
作者
Pare, Mathilde [1 ,2 ]
Goupil, Remi [3 ]
Fortier, Catherine [1 ,2 ,4 ]
Mac-Way, Fabrice [1 ,2 ]
Madore, Francois [3 ]
Hametner, Bernhard [5 ]
Wassertheurer, Siegfried [5 ]
Schultz, Martin G. [6 ]
Sharman, James E. [6 ]
Agharazii, Mohsen [1 ,2 ]
机构
[1] CHU, Quebec Hosp, Quebec Res Ctr, Hotel Dieu, Quebec City, PQ, Canada
[2] Univ Laval, Fac Med, Dept Med, Div Nephrol, Quebec City, PQ, Canada
[3] Hop Sacre Coeur Montreal, Dept Med, Montreal, PQ, Canada
[4] Paris Cardiovasc Res Ctr PARCC, INSERM, U970, Paris, France
[5] AIT Austrian Inst Technol, Ctr Hlth & Bioresources, Dept Hlth & Environm, Vienna, Austria
[6] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia
关键词
blood pressure; cardiovascular disease; hemodynamics; hypertension; nephrology and kidney; VASCULAR ACCESS; CARDIOVASCULAR EVENTS; AORTIC STIFFNESS; WAVE ANALYSIS; MORTALITY; ASSOCIATIONS; VALIDATION; OUTCOMES; OUTPUT; FORM;
D O I
10.1093/ajh/hpab161
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
BACKGROUND Reservoir-wave analysis (RWA) separates the arterial waveform into reservoir and excess pressure (XSP) components, where XSP is analogous to flow and related to left ventricular workload. RWA provides more detailed information about the arterial tree than traditional blood pressure (BP) parameters. In end-stage renal disease (ESRD), we have previously shown that XSP is associated with increased mortality and is higher in patients with arteriovenous fistula (AVF). In this study, we examined whether XSP increases after creation of an AVF in ESRD. METHODS Before and after a mean of 3.9 +/- 1.2 months following creation of AVF, carotid pressure waves were recorded using arterial tonometry. XSP and its integral (XSPI) were derived using RWA through pressure wave analysis alone. Aortic stiffness was assessed by carotid-femoral pulse wave velocity (CF-PWV). RESURLTS In 38 patients (63% male, age 59 +/- 15 years), after AVF creation, brachial diastolic BP decreased (79 +/- 10 vs. 72 +/- 12 mm Hg, P = 0.002), but the reduction in systolic BP, was not statistically significant (133 +/- 20 vs. 127 +/- 26 mm Hg, P = 0.137). However, carotid XSP (14 [12-19] to 17 [12-22] mm Hg, P = 0.031) and XSPI increased significantly (275 [212-335] to 334 [241-439] kPa center dot s, P = 0.015), despite a reduction in CF-PWV (13 +/- 3.6 vs. 12 +/- 3.5 m/s, P = 0.025). CONCLUSIONS Creation of an AVF resulted in increased XSP in this population, despite improvement in diastolic BP and aortic stiffness. These findings underline the complex hemodynamic impact of AVF on the cardiovascular system.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 50 条
[21]   Cardiac remodeling after reduction of high-flow arteriovenous fistulas in end-stage renal disease [J].
Wohlfahrt, Peter ;
Rokosny, Slavomir ;
Melenovsky, Vojtech ;
Borlaug, Barry A. ;
Pecenkova, Vera ;
Balaz, Peter .
HYPERTENSION RESEARCH, 2016, 39 (09) :654-659
[22]   Central pulse pressure and mortality in end-stage renal disease [J].
Safar, ME ;
Blacher, J ;
Pannier, B ;
Guerin, AP ;
Marchais, SJ ;
Guyonvarc'h, PM ;
London, GM .
HYPERTENSION, 2002, 39 (03) :735-738
[23]   End-Stage Renal Disease: Medical Management [J].
Wouk, Noah .
AMERICAN FAMILY PHYSICIAN, 2021, 104 (05) :493-499
[24]   Research Priorities for Percutaneous Arteriovenous Fistula Creation in Patients with End-Stage Renal Disease: Proceedings and Recommendations from a Multidisciplinary Research Consensus Panel [J].
Mobley, David ;
Kalloo, Sean D. ;
Baskin, Kevin M. ;
Koh, Elsie ;
McLennan, Gordon ;
Narayan, Rajeev ;
Towbin, Richard ;
White, Sarah ;
Weintraub, Joshua L. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 32 (08) :1240.e1-1240.e8
[25]   Sepsis in end-stage renal disease patients: are they at an increased risk of mortality? [J].
Chebl, Ralphe Bou ;
Tamim, Hani ;
Abou Dagher, Gilbert ;
Sadat, Musharaf ;
Ghamdi, Ghassan ;
Itani, Abdulrahman ;
Saeedi, Alawi ;
Arabi, Yaseen M. .
ANNALS OF MEDICINE, 2021, 53 (01) :1737-1743
[26]   Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease [J].
Reddy, Yogesh N. V. ;
Obokata, Masaru ;
Dean, Patrick G. ;
Melenovsky, Vojtech ;
Nath, Karl A. ;
Borlaug, Barry A. .
EUROPEAN HEART JOURNAL, 2017, 38 (24) :1913-1923
[27]   Blood Pressure Indexes and End-Stage Renal Disease Risk in Adults With Chronic Kidney Disease [J].
Bell, Emmy K. ;
Gao, Liyan ;
Judd, Suzanne ;
Glasser, Stephen P. ;
McClellan, William ;
Gutierrez, Orlando M. ;
Safford, Monika ;
Lackland, Daniel T. ;
Warnock, David G. ;
Muntner, Paul .
AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (07) :789-796
[28]   Efficacy of cilostazol in promoting the maturation of newly created arteriovenous fistula in patients with end-stage renal disease: a systematic review and metaanalysis [J].
Willim, Herick Alvenus ;
Sugandi, Erica ;
Rosa ;
Sani, Alvin Ariyanto ;
Khouw, Hengky .
MEDICAL JOURNAL OF INDONESIA, 2024, 33 (01) :35-41
[29]   Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death [J].
Dalrymple, Lorien S. ;
Katz, Ronit ;
Kestenbaum, Bryan ;
Shlipak, Michael G. ;
Sarnak, Mark J. ;
Stehman-Breen, Catherine ;
Seliger, Stephen ;
Siscovick, David ;
Newman, Anne B. ;
Fried, Linda .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (04) :379-385
[30]   Percutaneous arteriovenous fistula creation in the management of severe Hemophilia A and end-stage kidney disease needing hemodialysis access, and beyond [J].
Parkash, Shanti ;
Pena, Camilo ;
Cepak, Joshua ;
Kimberly, Robison ;
Zachariah, Mareena ;
Li, Wei .
JOURNAL OF VASCULAR ACCESS, 2024, 25 (03) :1023-1028